Background
==========

The delta opioid peptide \[D-Ala2, D-Leu5\]enkephalin (DADLE) has been shown to play a role in neuronal protection against hypoxic ischemia. However, the cellular mechanisms of these actions of DADLE on neurons are not totally clear. Being an *in-vitro*model of brain ischemia, oxygen-glucose deprivation (OGD) injury in rat brain slices has the advantages of both *in-vivo*and *in-vitro*models, and therefore can imitate damages induced by brain I/R injury in intact animals. In the present study, we examined the protective mechanism(s) of DADLE against apoptosis using a rat brain slice model. In addition, we determined whether δ-opioid receptors are unique and have a specific role in neuroprotection against OGD injury by activating the MAPK pathway, specifically through δ2-opioid receptors.

Methods
=======

The brain slices were injured by OGD, and then incubated with different concentrations of DADLE. Selective δ2-opioid antagonist or selective inhibitor of ERK kinase was co-incubated with or without DADLE. The effects of DADLE against apoptosis in neurons were measured by the following biochemical and morphological assays: the LDH release, RT-PCR, western blot, and TUNEL staining.

Results
=======

This protective effect of DADLE is U-shaped as demonstrated in the dose--response curves. It was found that micromolar concentrations of DADLE are antiapoptotic, whereas micromolar concentrations of DADLE lack apparent protective effects. The protective effect of DADLE can be attenuated by a selective δ2-opioid antagonist. The treatment of cells with PD98059, a selective inhibitor of ERK kinase (MEK), blocked both the protective effect of DADLE and the ERK phosphorylation induced by DADLE.

Conclusion
==========

Our results suggest, therefore, that endogenous opioid peptides may, at low concentrations, promote cell survival via the MEK--ERK pathway, perhaps through δ2-opioid receptors.
